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FDG PET/CT Imaging and Quantification
FDG PET/CT image acquisition, reconstruction, and attenuation correction were performed as previously described (16) . After patients had fasted for at least 4 hours, FDG (5.4 MBq per kilogram of body weight; maximum 12 mCi) was injected intravenously. One consent was received from all enrolled patients. Thirty-four patients with newly diagnosed high-grade osteosarcoma were prospectively enrolled from June 2008 to May 2012 in a clinical trial (trial NCT00667342) and underwent FDG PET/CT imaging, NCT, and subsequent surgical resection. The eligibility criteria included age 30 years or younger; newly diagnosed, confirmed with histologic analysis, high-grade, resectable osteosarcoma; Karnofsky or Lansky performance score of 50 or greater or World Health Organization/Eastern Cooperative Oncology Group performance score of 2 or less; and no previous chemotherapy or radiation therapy. The exclusion criteria included osteosarcoma as a second malignancy or a major surgical procedure or significant traumatic injury within 28 days of study entry or known bleeding diathesis. Other organ-specific inclusion/exclusion criteria are provided in Appendix E1 [online] .
Patients received a uniform protocol of NCT in St. Jude Children's Research Hospital (Memphis, Tenn), which consisted of the following: cisplatin; doxorubicin at weeks 0 and 5; high-dose methotrexate at weeks 3, 4, 8, and 9; and bevacizumab at weeks 0, 3, and 5. FDG PET/CT imaging was performed before (baseline scan), during (5 weeks after initiation of NCT, interim scan), and after NCT (10 weeks after initiation of NCT, posttherapy scan).
Twenty-nine of the thirty-four patients were previously reported in an abstract (14) . This previous abstract evaluated the difference of primary tumor SUV max between routine (~1 hour after FDG injection) and delayed (~3 hours after FDG injection) imaging times, whereas we report the prognostic value of multiple FDG PET parameters, including SUV max , SUV peak , MTV, and TLG. Also, in the same group of patients who participated in our study, the predictive value of SUV max from FDG PET for histologic response was evaluated, and SUV max at 5 and 10 weeks was found to be predictive of histologic response (15) . Histologic response to NCT was evaluated by examination of postsurgical tumor specimen after surgical resection compared with Abbreviations: 2SD = two SD EFS = event-free survival FDG = fluorodeoxyglucose MTV = metabolic tumor volume NCT = neoadjuvant chemotherapy OS = overall survival SD = standard deviation SUV = standardized uptake value SUV max = maximum SUV SUV peak = peak SUV TLG = total lesion glycolysis
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Guarantor of integrity of entire study, S.Y.C.; study concepts/ study design or data acquisition or data analysis/interpretation, all authors; manuscript drafting or manuscript revision for important intellectual content, all authors; approval of final version of submitted manuscript, all authors; agrees to ensure any questions related to the work are appropriately resolved, all authors; literature research, H.J.I., Y.Z., J. O steosarcoma is a common primary bone malignancy in children and adolescents. The standard care of treatment for high-grade osteosarcoma includes neoadjuvant chemotherapy (NCT) and subsequent surgical resection. The most important prognostic factors are initial tumor stage and histologic response after NCT (1, 2) . However, even with the same stage and histologic response, survival of patients could differ substantially, and histologic response only can be evaluated after surgical resection. Because changing treatment postoperatively does not improve patient outcomes, a preoperative prognostic factor could be useful for further risk stratification before the surgical resection (3) .
The quantitative parameters derived from fluorine 18 fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) showed prognostic value in a variety of malignancies (4-7). Recent metaanalyses showed that various FDG PET parameters including maximum standardized uptake value (SUV; SUV max ), metabolic tumor volume (MTV), and total lesion glycolysis (TLG) were prognostic factors in multiple types of malignancies (6, (8) (9) (10) . Peak SUV (SUV peak ) is also reported to be a prognostic factor in non-small cell lung cancer (11) . In osteosarcoma, few retrospective studies assessed the prognostic value of FDG PET parameters including SUV max and MTV (3, 7, 12, 13) . However, there has been no consensus on selection of an optimal parameter and time to predict survival in osteosarcoma because, to our knowledge, no systematic or prospective study has been conducted to evaluate the predictive value and prognostic significance of various FDG PET/CT parameters before, during, and after NCT.
In our prospective study, we aimed to preliminarily assess the potential prognostic value of various FDG PET parameters before, during, and after NCT. 
Materials and Methods

Patients
Statistical Analysis
Associations between histologic response and categorical clinical and pathologic parameters were determined by using a x 2 test (two categories) or KruskalWallis test (three or more categories). Each PET parameter was divided into two groups by using an optimized cut-off value for further analysis. The optimized cut-off value was determined by the maximum Youden index from receiver operating characteristic analysis. Each FDG PET/CT parameter was compared between responders and poor responders by using the Wilcoxon rank-sum test. EFS and OS distributions between FDG PET parameter groups were compared by using the log-rank test. Multivariable Cox regression analysis was performed to study the association between individual FDG PET parameters and EFS and OS after adjusting for histologic response and initial presence of metastasis. All statistical analyses were performed by using software (SAS version 9.3 for Windows; SAS Institute, Cary, NC). P values were adjusted for multiple comparison on the basis of the method of false discovery rate. P values less than .05 were considered to indicate statistical significance.
Results
Patient Characteristics
We enrolled 34 patients; their clinical and pathologic characteristics are summarized in Spherical volume of interest was drawn to include the primary osteosarcoma lesion on the FDG PET images. SUV max and SUV peak within the volume of interest were measured. The tumor boundaries were defined by using various SUV thresholds that were absolute (SUV 2.0, SUV 2.5), relative percent tumor SU-V max (40% or 60% of the tumor SUV max ), and mean liver SUV + one standard deviation (SD) or two SDs (2SD). Mean liver SUV and standard deviation were measured by using a 3-cm (diameter) spherical volume of interest on the right lobe of the liver. MTVs were defined as the tumor volumes inside the tumor boundaries by using the various SUV thresholds and named as follows with their SUV thresholds inside the parenthesis: MTV (SUV 2.0), MTV (SUV 2.5), MTV (40%), MTV hour after the injection, transmission CT and PET scans were performed from the top of the skull to the feet. Nine patients (26%) had metastatic lesions before initiation of treatment (seven in lung; one in bone; one in lung and bone). Of note, two patients were considered to be non-evaluable for histologic response because surgical resection was not performed at the protocol specified time (ie, week 10).
Association with Histologic Response
Histologic responses after NCT were evaluable in 32 patients, and 15 were classified as responders and the others as poor responders. Age, sex, site of primary tumor, initial presence of metastasis, and type of pathology were not associated with histologic response (Table 2) . Also, none of the FDG PET parameters at baseline were associated with histologic response. However, at the interim scans, SUV max , SUV peak , MTV (liver + 2SD), TLG (liver + 2SD) showed statistically significant association with histologic response (P = .03-.04). Moreover, at the posttherapy scans, parameters except MTV (40%), MTV (60%), TLG (40%), and TLG (60%) were associated with histologic response (P = .0002-.02); MTV (liver + 2SD) and TLG (liver + 2SD) were the most statistically significant parameters (MTV [liver + 2SD] of poor responders vs responders: 78.7 6 74.3 vs 2.8 6 6.9, respectively; P , .0002; TLG [liver + 2SD] poor responders vs responders: 272.9 6 319.1 vs 6.6 6 15.6, respectively; P , .0002). Similarly, among percent change between baseline and interim FDG PET parameters, percent change (baseline to interim) of all parameters except MTV (40%), MTV (60%), TLG (40%), and TLG (60%) were associated with histologic response (P = .003-.04). Percent change (baseline to interim) of MTV (liver + SD) was the most statistically significant parameter (P = .003). Lastly, among percent change between baseline and posttherapy FDG PET/ CT values, percentage change (baseline to posttherapy scan) of all parameters except MTV (60%), TLG (40%), and TLG (60%) were associated with histologic response (P = .0002-.01), and 30.5% vs 298.9% 6 3.0%, respectively; P = .00023). To summarize, posttherapy and percent change (baseline to posttherapy) FDG PET parameters showed the greatest statistical associations with histologic response. Among the volumetric parameters using various thresholds, MTV and TLG using a threshold of 2.0, 2.5, liver + SD and liver + 2SD showed the better association with histologic response than MTV and TLG by using relative thresholds (Fig E1, Table E1 [online]).
Evaluation of Prognostic Factors for EFS
Baseline FDG PET parameters were predictive of EFS except SUV max , MTV (60%), MTV (liver + 2SD), TLG (60%); MTV (SUV 2.0) and TLG (SUV, 2.5) were the most statistically significant parameters (P = .006, for both) (Fig E2  [online] ). Also, all FDG PET parameters at interim scan were predictive of EFS except MTV (40%), MTV (60%), and TLG (40%), whereas MTV (SUV, 2.5) was the most statistically significant parameter (P = .004). Similarly at posttherapy scan, FDG PET parameters were predictive of EFS except MTV (40%), MTV (60%), TLG (40%), and TLG (60%), whereas MTV (liver + 2SD) was the most statistically significant parameter (P = .01). However, among percent changes between baseline and interim FDG PET/CT scans, only percent change (baseline to interim) of TLG (60%) was predictive of EFS (P = .01). Among percent changes between baseline and posttherapy scans, only percent change (baseline to posttherapy) of SUV peak and MTV (SUV, 2.0)
were the parameters to show predictive value for EFS (P = .036 and 0.033, respectively). In summary, metabolic parameters (SUV peak ) and volumetric parameters (MTV and TLG) were predictive of EFS at all points (baseline, interim, and posttherapy), and percent change of the parameters was not better than those from the single scan ( Fig  E2, Table E2 [online]). Notably, SUV peak , MTV (SUV, 2.5), and TLG (SUV, 2.5) at baseline could predict EFS (P = .01, .01, and .006, respectively) (Fig 1) . In volumetric parameters, parameters measured by thresholds of absolute and liver-based thresholds were better than those by relative thresholds in predicting EFS. In particular, MTV measured by using relative threshold at interim and posttherapy imaging did not accurately visually represent the tumor volume, and could not predict the outcome of patients who showed a favorable response (Fig 2) . Histologic
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absolute or liver-based thresholds were better than relative thresholds to predict OS. Histologic response and initial presence of metastasis were also predictive of OS (P = .047 and .026, respectively). Multivariable Cox regression analysis for OS was performed by using SUV max , SUV peak , MTV (SUV, 2.5), TLG (SUV, 2.5), MTV (liver + 2SD), and TLG (liver + 2SD). Initial presence of metastasis and histologic response were used as covariates. At baseline scan, MTV (SUV, 2.5), TLG (SUV, 2.5), and TLG (liver + 2SD) were independent prognostic factors for OS, whereas SUV max and SUV peak were not. For example, a patient with small MTV (SUV, 2.5) (24.9 mL) (Fig 4a) interim) of TLG (60%) was predictive of OS (P = .01). Among percent change between baseline and posttherapy FDG PET/CT scans, only percent change (baseline to after therapy) of MTV (SUV, 2.0), MTV (40%), and TLG (SUV, 2.5) were parameters to show predictive value for OS (P = .03 ~ 0.04). Overall, FDG PET parameters from a single-point scan (baseline, interim, or posttherapy) were predictive of OS, and percent changes of the parameters were less predictive than those from a single-point scan (Fig E3,  Table E3 [online]). In particular, SUVpeak , MTV (SUV, 2.5), and TLG (SUV, 2.5) at baseline could predict OS (P = .02, .004, and .001, respectively) (Fig 3) . For volumetric parameters, response and initial presence of metastasis tended to be predictive of EFS (P = .069 and .056, respectively).
Multivariable Cox regression analysis for EFS was performed by using SUV max , SUV peak , MTV (SUV, 2.5), TLG (SUV, 2.5), MTV (liver + 2SD), and TLG (liver + 2SD). Initial presence of metastasis and histologic response were used as covariates. Even at baseline scan, MTV (SUV, 2.5), TLG (SUV, 2.5), and TLG (liver + 2SD) were independent prognostic factors for EFS. At interim scan, MTV (SUV, 2.5), TLG (SUV, 2.5) were independent prognostic factors for EFS. At posttherapy scan, MTV (liver + 2SD) and TLG (liver + 2SD) were predictive of EFS independently. Notably, MTV (SUV, 2.5) and TLG (SUV, 2.5) were independent prognostic factors for EFS at baseline (MTV [ 
Evaluation of Prognostic Factors for OS
FDG PET parameters at baseline were predictive of OS except SUV max , MTV (60%), MTV (liver + 2SD), and TLG (60%), whereas MTV (SUV, 2.0), TLG (SUV, 2.0), and TLG (SUV, 2.5) were the most statistically significant parameters (P = .001 for all). At interim FDG PET/CT scan, FDG PET parameters were predictive of OS except MTV (40%), MTV (60%), TLG (40%), and TLG (60%), whereas MTV (SUV, 2.0), MTV (SUV, 2.5), and TLG (SUV, 2.5) were the most significant parameters (P = .001, for all). Also at posttherapy scan, FDG PET parameters were predictive of OS except MTV (40%), MTV (60%), TLG (40%), and TLG (60%); SUV max , SUV peak , MTV (SUV, 2.5), and TLG (SUV, 2.5) were the most statistically significant parameters (P = .002, for all).
Among percent changes between baseline and interim FDG PET/CT scans, only percent change (baseline to Note.-Data in parentheses are 95% confidence intervals (CIs). These parameters were adjusted for histologic response and initial presence of metastasis. All P values were adjusted based on the method of false discover rate. SUV max = maximum standardized uptake value, SUV peak = peak standardized uptake value, MTV (SUV 2.5) = MTV with threshold of SUV 2.5, MTV (liver + 2SD) = MTV with relative threshold of mean liver SUV + 2 standard deviation, TLG (SUV 2.5) = TLG with threshold of SUV 2.5, TLG (liver + 2SD) = TLG with liver based threshold of mean liver SUV + 2 standard deviation.
* Hazard ratio and CI were not stated when the CI tended toward infinity.
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showed a good outcome despite a poor histologic response after NCT. On the other hand, patients with large MTV (SUV, 2.5) experienced worse outcomes independent of histologic response after NCT (Figs 4b, 4c) . At interim scan, only TLG (SUV, 2.5) and TLG (liver + 2SD) were independent prognostic factors for OS. Finally, at posttherapy scan, SUV max , SUV peak , MTV (SUV, 2.5), and TLG (SUV, 2.5) were independently predictive of OS. SUV max and SUV peak were independent prognostic factors for OS only at posttherapy scans. However, TLG (SUV, 2.5) was an independent prognostic factor for OS at all points (baseline TLG 
Discussion
We evaluated prognostic value of various FDG PET parameters before, during, and after NCT. We demonstrated that SUV max , SUV peak , MTV, and TLG at interim and posttherapy scans are associated with histologic response but not at baseline scan. MTV and TLG at baseline, interim, and posttherapy scans were predictive of EFS and OS after adjusting known prognostic factors. Prognostic value of FDG PET in osteosarcoma was reported in some retrospective studies (3, 7, 12, 13) . Franzius et al (12) reported that higher tumorto-nontumor ratio of FDG uptake correlated with poor outcome. Sato et al also reported that tumor SUV max after NCT is associated with poor prognosis (13). Costelloe et al (7) showed that SUV max was predictive of EFS both before and after NCT, and also SUV max before NCT was predictive of OS. Additionally, TLG before NCT was predictive of OS but not of EFS. Additionally, MTV before NCT was an independent predictor of metastasis-free survival (3). To our knowledge, our study was the first prospective study to evaluate the prognostic value of FDG PET/CT by systematically 
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Im et al remained independent of stage and histologic response as additional prognostic factors for clinical outcome (EFS and OS). Although to our knowledge SUV max is the most widely used FDG PET parameter, the value is measured from only one voxel, and thus could be affected by noise or artifact (17) . SUV peak has been proposed to overcome the shortcoming of SUV max , defined as the average SUV within a small, fixed size region of interest centered on a high uptake part of the tumor (18) . SUV peak has been reported (11, 19, 20) to be prognostic in several types of malignancy. In patients with osteosarcoma, we revealed that SUV peak at the posttherapy scan is an independent prognostic factor for OS.
Multiple threshold methods of deriving MTV have been used in studies to predict survival in various malignancies, scan. In a previous study (15) from our group that used the same patient data, we reported that there was no significant correlation between EFS and SUV max at baseline, interim, and posttherapy scan. However, in the prior study, we only analyzed the correlation between the continuous values of EFS and SUV max , which may lead to underestimation of the association. However, we dichotomized the patients according to various FDG PET parameters so that we could find the predictive values of the parameters in our study.
MTV was reported (3) to be an independent predictor of metastasisfree survival in patients with osteosarcoma, after adjustment for American Joint Committee on Cancer stage and histologic response, which are known powerful predictors of survival. In our study, various FDG PET parameters testing the predictive value of various parameters (SUV max , SUV peak , MTV, and TLG) with three scans at various points (at baseline, interim, and posttherapy) for three different types of end points (histologic response, EFS, and OS). Our study reproduced the individual results of the previous retrospective studies and further confirmed the prognostic value of FDG PET/CT. Additional information gained from our study is as follows: (a) SUV peak was associated with histologic response (interim and posttherapy scan) and predictive of EFS and OS (at all points); (b) at the interim scan, SUV max , SUV peak , MTV, and TLG were predictive of EFS and OS; (c) MTV and TLG have prognostic value for EFS and OS at all points; and (d) percent change of the parameters did not provide better prognostic value compared with those from single-point 
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Our study has several limitations. First, our study was an exploratory study and thus was not planned with power analysis. Second, we analyzed relatively small sample size from a single institute which may limit generalizability. However, our study is a prospective study of patients uniformly treated and evaluated at fixed intervals to determine the prognostic value of metabolic and volumetric parameters of FDG PET/CT in pediatric patients with osteosarcoma. Another limitation of our study is the adequate but somewhat limited clinical follow-up time for the survived patients (median, 44 months; range, 17-61 months) and exclusion of two patients for histologic analysis.
In summary, a single-point FDG PET/CT scan either at baseline, interim, or posttherapy was predictive of EFS and OS even after adjusting for histologic response and initial presence of metastasis. Volumetric parameters by using absolute SUV threshold or liver-based threshold were comparable to predict EFS and OS; however, relative threshold was not consistently predictive. These findings need further validation in larger prospective multi-institutional studies before these parameters could be used as a prognostic and predictive biomarker during treatment for risk stratification and therapy adjustment. PET tumor volume. MTV by using a relative threshold with 40% and 60% tumor SUV max tended to underestimate the PET tumor volume at baseline scans in tumors with very high SUV max , and overestimate PET tumor volume at interim and posttherapy scans because of decreasing tumor SUV max after NCT. This result also has been reported in a previous study by Erdi et al (24) , which showed underestimation of the volume by using relative threshold method in a tumor with low signal to background. Thus, our data indicate that measuring MTV by using fixed or liver-based thresholds is superior for prediction of outcome than relative threshold for high tumor SUV max baseline scans and especially at interim or posttherapy scans.
including absolute SUV threshold methods such as SUV 2.0 or SUV 2.5 (21), relative threshold methods such as 40%-60% of SUV max of the lesion (22) , and liver-based threshold methods (23) . Among osteosarcoma studies, Costelloe et al (7) used 45% of SUV max , while Byun et al (3) used SUV 2.0 and 2.5, and 45% of SUV max . In our study, we used multiple thresholds to define MTV including absolute thresholds, relative thresholds, and liver-based thresholds, and the predictive values of these volumetric parameters were comparatively assessed. We found that prognostic values of volumetric parameters measured by using absolute and liver-based thresholds were comparable and better than those measured by using relative thresholds to accurately represent the Note.-Data in parentheses are 95% confidence intervals (CIs). The parameters were adjusted for histologic response and initial presence of metastasis. All P values were adjusted on the basis of the method of false discover rate. SUV max = maximum standardized uptake value, SUV peak = peak standardized uptake value, MTV (SUV 2.5) = MTV with threshold of SUV 2.5, MTV (liver + 2SD) = MTV with relative threshold of mean liver SUV + 2 standard deviation, TLG (SUV 2.5) = TLG with threshold of SUV 2.5, TLG (liver + 2SD) = TLG with liver based threshold of mean liver SUV + 2 standard deviation.
